DEPDC1B and prostate carcinoma: Moreover, accumulating evidence demonstrated that DEPDC1B is overexpressed in diverse types of cancers such as non-small cell lung cancer, oral cancer, prostate cancer, soft tissue sarcoma, cervical cancer, and malignant melanoma (14–19).